ABT Shariah Compliance
Screening Methodology: AAOIFI
LOCKED
Abbott Laboratories. Stock Analysis ABT
United States Health Care Mega Cap Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products. The company is headquartered in Abbott Park, Illinois and currently employs 114,000 full-time employees. The Company’s principal business is the discovery, development, manufacture, and sale of a broad and diversified line of healthcare products. Its segments include Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. Diagnostic Products segment is involved in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. Nutritional Products segment is engaged in the worldwide sales of a broad line of adult and pediatric nutritional products. Medical Devices segment is involved in the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation and diabetes care products. The company serves people in more than 160 countries.
Read More ABT Chart
Abbott Laboratories vs S&P 500 Comparative Returns
Analysis of ABT stock performance compared to the broader market (S&P 500) across multiple timeframes.
YTD Performance
- Abbott Laborato... (ABT...) 15.83%
- S&P 500 8.2%
Abbott Laboratories Outperformed S&P 500 by 7.63%
1Y Performance
- Abbott Laborato... (ABT...) 21.54%
- S&P 500 17.63%
Abbott Laboratories Outperformed S&P 500 by 3.91%
3Y Performance
- Abbott Laborato... (ABT...) 17.53%
- S&P 500 54.54%
Abbott Laboratories Underperformed S&P 500 by 37.01%
5Y Performance
- Abbott Laborato... (ABT...) 29.59%
- S&P 500 94.73%
Abbott Laboratories Underperformed S&P 500 by 65.14%
Key Statistics of Abbott Laboratories (ABT)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$129.11Volume
6.72MP/E Ratio (TTM)
16.2852 Week Range
Market Cap
218.75BAvg. Volume
7.75MDividend Yield
1.79%Financial Metrics & Statements of Abbott Laboratories (ABT)
- Per Share Data
- Ratios
- Statements
| Currency: USD | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
Revenue per Share (TTM) | 19.54 | 24.42 | 25.12 | 23.13 | - |
EBIT per Share (TTM) | 3.07 | 4.87 | 5.01 | 3.88 | - |
Earnings per Share (EPS) (TTM) | 2.52 | 3.97 | 3 | 3 | - |
Dividend per Share (TTM) | 1.45 | 1.82 | 1.9 | 2.05 | - |
EPS Forward | - | - | 3.93 | 3.27 | 7.67 |
Annual 
Quarterly
| Currency: USD | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
Net Margin | 0.13 | 0.16 | 0.16 | 0.14 | 0.32 |
Quick Ratio | 1.14 | 1.28 | 1.06 | 1 | 1.05 |
Current Ratio | 1.72 | 1.85 | 1.63 | 1.64 | 1.67 |
Price to Earnings (TTM) | 0 | 0 | 0 | 0 | 0 |
price_to_earning | 0 | 0 | 0 | 0 | 0 |
Price to Sales (TTM) | 0 | 0 | 0 | 0 | 0 |
Price to Book | 5.92 | 6.95 | 5.22 | 4.95 | 4.12 |
Free Cash Flow Margin | 0.17 | 0.2 | 0.18 | 0.13 | 0.15 |
Payout Ratio (TTM) | 0 | 0 | 0 | 0 | 0 |
Gross Margin | 0.57 | 0.57 | 0.56 | 0.55 | 0.55 |
Return on Equity (TTM) | 0 | 0 | 0 | 0 | 0 |
Return on Assets | 0.06 | 0.09 | 0.09 | 0.08 | 0.16 |
Return on Assets (TTM) | 0 | 0 | 0 | 0 | 0 |
Return on Invested Capital | 0.09 | 0.13 | 0.13 | 0.11 | 0.22 |
Inventory Turnover (TTM) | 0 | 0 | 0 | 0 | 0 |
Receivables Turnover (TTM) | 0 | 0 | 0 | 0 | 0 |
Asset Turnover (TTM) | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt to Equity | 0.57 | 0.48 | 0.4 | 0.35 | 0.26 |
Total Debt to Total Asset | 0.26 | 0.24 | 0.23 | 0.2 | 0.17 |
Long-Term Debt to Total Asset | 0.26 | 0.23 | 0.2 | 0.19 | 0.16 |
Total Debt to Total Capital | 0.36 | 0.34 | 0.31 | 0.28 | 0.23 |
Operating Margin | 0.16 | 0.2 | 0.19 | 0.16 | 0.17 |
Price to Earning | 43.45 | 35.45 | 36.6 | 36.69 | - |
Super Investors invested in Abbott Laboratories (ABT)
Super Investors are top-performing investors known for their exceptional market strategies and long-term success in wealth creation.
Robert Bruce
% Portfolio:
5.69 Recent Activity:-9.78%
Ken Fisher
% Portfolio:
0.67 Recent Activity:3.33%
Jefferies Group
% Portfolio:
0.56 Recent Activity:22.01%
Joel Greenblatt
% Portfolio:
0.06 Recent Activity:42.66%
Community-Curated Collections with Abbott Laboratories (ABT)
View AllCommunity-Curated Collections are thoughtfully selected groups of stocks or assets, curated by investors and experts based on shared themes, values, or investment strategies.
shariah list nifty 50
By trading view
2111 Followers
HALAL STOCK of india
By Aasif Khan
1877 Followers
My Halal AI Stocks Technology - 2024
By Doniyor Akhmadjon
661 Followers
Recent Halal Top Performers US
By Doniyor Akhmadjon
441 Followers
Dow Jones Industrial Average Index
By Dilnoza Mirsaidova
236 Followers
Zero Debt Stocks in India
By Javokhir Suyundikov
122 Followers
1st HALAL NIFTY SMALLCAP 250
By Abdul Mannan
110 Followers
Halal stocks in INDIA
By Altaf Khan
109 Followers
IT Sector Stocks in India
By Javokhir Suyundikov
107 Followers
Halal Divident Stock
By Monirul Islam
99 Followers
FAQ's for Abbott Laboratories (ABT)
Halal stocks refer to shares of companies that comply with Islamic finance principles, meaning they do not engage in businesses related to alcohol, gambling, pork, or interest-based financial services.
Alternate Halal Stocks for Abbott Laboratories (ABT)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
